ArticleResearch square2025
Impact of the COVID-19 Pandemic on BMI and Obesity among Underrepresented Populations: A Longitudinal Analysis of the All of Us Dataset.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: The COVID-19 pandemic and its prevention measures (e.g., quarantine, social distancing, and shutdown) significantly affected people's physical activity and lifestyle, potentially increasing Body Mass Index (BMI) and risk of obesity. This study provides a comprehensive analysis to examine changes in BMI and obesity rate across pre-COVID, COVID, and post-COVID periods, and to identify the sociodemographic correlates of BMI and obesity change. Methods: Longitudinal electronic health record data from the All of Us Research Program for adults ≥ 18 years with at least one BMI record in each period (N = 38,632) were analyzed. Periods were defined as pre-COVID (Jan 1, 2018-Mar 12, 2020), COVID (Mar 13, 2020-Dec 31, 2021), and post-COVID (Jan 1, 2022-Oct 31, 2023). We modeled BMI with a linear mixed-effects model and obesity (BMI ≥ 30) with a GEE logit model, adjusting for age, sex, race, ethnicity, income, and employment; time was modeled with linear and quadratic terms, and we tested time × subgroup interactions. Results: Mean BMI increased from 30.05 pre-COVID to 30.14 during COVID, then declined to 29.96 post-COVID; obesity prevalence followed a similar pattern (43.5% → 44.1% → 43.2%). In adjusted models, linear time effects were positive and the quadratic terms negative for both outcomes, indicating non-linear (increase-then-partial-reversal) trends (BMI: β_time = 0.216; β_time Conclusion: BMI and obesity increased during the pandemic and partially reversed afterward, but persistent disparities remained, with higher risk among women, Black and Hispanic/Latino adults, and lower-income groups. Results highlight the impact of COVID-19 on obesity risk and emphasize the need for proactive measures to promote healthier lifestyle and weight management strategies for vulnerable groups in future public health preparedness plans.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.